Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online January 24, 2008
Stem Cells Vol. 26 No. 4 April 2008, pp. 1074 -1082
doi:10.1634/stemcells.2007-0898; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0898v1
26/4/1074    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singhal, S.
Right arrow Articles by Limb, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singhal, S.
Right arrow Articles by Limb, G. A.

TRANSLATIONAL AND CLINICAL RESEARCH

Chondroitin Sulfate Proteoglycans and Microglia Prevent Migration and Integration of Grafted Müller Stem Cells into Degenerating Retina

Shweta Singhala, Jean M. Lawrencea, Bhairavi Bhatiaa, James S. Ellisa, Anthony S. Kwana, Angus MacNeila, Philip J. Lutherta, James W. Fawcettb, Maria-Thereza Perezc,d, Peng T. Khawa, G. Astrid Limba

aInstitute of Ophthalmology and Moorfields Eye Hospital, London, United Kingdom;
bCentre for Brain Repair, University of Cambridge, Cambridge, United Kingdom;
cDepartment of Ophthalmology, Lund University, Lund, Sweden;
dDepartment of Ophthalmology, Glostrup Hospital, Glostrup, Denmark

Key Words. Adult stem cells • Cell migration • Stem cell transplantation • Experimental models • Tissue regeneration Tissue-specific stem cells

Correspondence: G. Astrid Limb, M.Sc., Ph.D., Ocular Repair and Regeneration Biology Unit, Departments of Cell Biology and Pathology, Institute of Ophthalmology, 11 Bath Street, London EC1V 9EL, United Kingdom. Telephone: 020-7608-6974; Fax: 020-7608-4034; e-mail: g.limb{at}ucl.ac.uk

Received October 30, 2007; accepted for publication January 20, 2008.
First published online in STEM CELLS EXPRESS   January 24, 2008.



At present, there are severe limitations to the successful migration and integration of stem cells transplanted into the degenerated retina to restore visual function. This study investigated the potential role of chondroitin sulfate proteoglycans (CSPGs) and microglia in the migration of human Müller glia with neural stem cell characteristics following subretinal injection into the Lister hooded (LH) and Royal College of Surgeons (RCS) rat retinae. Neonate LH rat retina showed minimal baseline microglial accumulation (CD68-positive cells) that increased significantly 2 weeks after transplantation (p < .001), particularly in the ganglion cell layer (GCL) and inner plexiform layer. In contrast, nontransplanted 5-week-old RCS rat retina showed considerable baseline microglial accumulation in the outer nuclear layer (ONL) and photoreceptor outer segment debris zone (DZ) that further increased (p < .05) throughout the retina 2 weeks after transplantation. Marked deposition of the N-terminal fragment of CSPGs, as well as neurocan and versican, was observed in the DZ of 5-week-old RCS rat retinae, which contrasted with the limited expression of these proteins in the GCL of the adult and neonate LH rat retinae. Staining for CSPGs and CD68 revealed colocalization of these two molecules in cells infiltrating the ONL and DZ of the degenerating RCS rat retina. Enhanced immune suppression with oral prednisolone and intraperitoneal injections of indomethacin caused a reduction in the number of microglia but did not facilitate Müller stem cell migration. However, injection of cells with chondroitinase ABC combined with enhanced immune suppression caused a dramatic increase in the migration of Müller stem cells into all the retinal cell layers. These observations suggest that both microglia and CSPGs constitute a barrier for stem cell migration following transplantation into experimental models of retinal degeneration and that control of matrix deposition and the innate microglial response to neural retina degeneration may need to be addressed when translating cell-based therapies to treat human retinal disease.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.